Search Results for “cardioform” | Gore

GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects

Data from the Gore ASSURED Clinical Study demonstrated 100 percent closure success at six months

Jun 4, 2019

Adult IC CARDIOFORM Brochure

GORE® CARDIOFORM Septal Occluder

PDF, 2.79 MB

Animation - GORE® CARDIOFORM Septal Occluder ASD

Video

GORE® CARDIOFORM ASD Occluder animation

Video

Gore Marks Two-Year Primary Endpoint Follow-up Milestone in Study of GORE® CARDIOFORM Septal Occluder for Patent Foramen Ovale (PFO) Closure

Completion of follow -up paves way for REDUCE Clinical Study data submission to FDA for PFO indication

Mar 30, 2017

Gore Completes Patient Enrollment in U.S. Pivotal Clinical Study of GORE® CARDIOFORM ASD Occluder

New addition to GORE® CARDIOFORM Occluder family is designed to treat larger atrial septal defects by adapting to the patient’s anatomy for a permanent and safe closure

Sep 26, 2017